InvestSMART

Emerald Resources NL (ASX: EMR) - Announcements

Current share price for EMR : $6.820 0.08 (1.16%)+

ASX company news and announcements for Emerald Resources NL (EMR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Emerald Resources NL (EMR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Emerald Resources NL (EMR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Emerald Resources NL (EMR)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$4,525 Change in substantial holding 17 Apr 2023 8:20AM $1.760 $6.820 risen by 287.50%
$4,525 Quarterly Gold Production - March 2023 13 Apr 2023 9:23AM $1.735 $6.820 risen by 293.08%
$4,525 Change in substantial holding 13 Apr 2023 8:23AM $1.735 $6.820 risen by 293.08%
$4,525 Half Yearly Report and Accounts 16 Mar 2023 10:24AM $1.480 $6.820 risen by 360.81%
$4,525 Appointment of Chief Financial Officer 14 Feb 2023 3:53PM $1.510 $6.820 risen by 351.66%
$4,525 Ceasing to be a substantial holder 3 Feb 2023 5:36PM $1.560 $6.820 risen by 337.18%
$4,525 Quarterly Activities/Appendix 5B Cash Flow Report 31 Jan 2023 9:40AM $1.390 $6.820 risen by 390.65%
$4,525 Significant Gold Exploration Results at Bullseye and Memot 31 Jan 2023 9:24AM $1.390 $6.820 risen by 390.65%
$4,525 Record Quarterly Gold Production 10 Jan 2023 8:20AM $1.230 $6.820 risen by 454.47%
$4,525 Proposed issue of securities - EMR 30 Dec 2022 8:22AM $1.180 $6.820 risen by 477.97%
$4,525 Cleansing Prospectus 30 Dec 2022 8:22AM $1.180 $6.820 risen by 477.97%
$4,525 Modern Slavery Statement 29 Dec 2022 3:49PM $1.180 $6.820 risen by 477.97%
$4,525 Application for quotation of securities - EMR 22 Dec 2022 6:14PM $1.200 $6.820 risen by 468.33%
$4,525 Application for quotation of securities - EMR 2 Dec 2022 7:24PM $1.145 $6.820 risen by 495.63%
$4,525 Change of Director's Interest Notice 25 Nov 2022 6:39PM $1.150 $6.820 risen by 493.04%
$4,525 Notification regarding unquoted securities - EMR 25 Nov 2022 6:35PM $1.150 $6.820 risen by 493.04%
$4,525 Results of Meeting 24 Nov 2022 3:13PM $1.130 $6.820 risen by 503.54%
$4,525 AGM Presentation 24 Nov 2022 12:58PM $1.120 $6.820 risen by 508.93%
$4,525 Proposed issue of securities - EMR 1 Nov 2022 6:22PM $1.105 $6.820 risen by 517.19%
$4,525 Notification regarding unquoted securities - EMR 1 Nov 2022 6:18PM $1.105 $6.820 risen by 517.19%
$4,525 ESOP Option Issue 1 Nov 2022 6:16PM $1.105 $6.820 risen by 517.19%
$4,525 Quarterly Activities/Appendix 5B Cash Flow Report 31 Oct 2022 9:04AM $1.090 $6.820 risen by 525.69%
$4,525 Notice of Annual General Meeting/Proxy Form 24 Oct 2022 4:15PM $1.135 $6.820 risen by 500.88%
$4,525 Annual Report to shareholders 24 Oct 2022 4:03PM $1.090 $6.820 risen by 525.69%
$4,525 Letter to Shareholders - AGM Materials 24 Oct 2022 4:02PM $1.090 $6.820 risen by 525.69%

401 - 425 of 1040 results

Page 17 of 42

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.